Right now, that means three things: Patients taking GLP-1 medications should proactively flag this to their dentist at every appointment Dentists should be asking every patient whether they are on weight-loss medication as a standard part of their clinical intake Prescribers should include oral health explicitly in the side effect briefing given to patients starting these drugs The data shows that awareness is rising
Cytokines like TNF can, in turn, induce COX-2 and NOX2 gene expression (Newton et al., 1997
Splitting the tablet would likely reduce this further, resulting in subtherapeutic blood levels and poor glycaemic control
This pattern matters because the familiar ways many users manage episodes, like: Scribbled notes or relying on memory Obscure timing Triggers as treatment changes Solutions like MeAgain centralize symptom timelines, link injections to meals and side effects, and tag injection sites so clinicians can see clean, patient-level data rather than fragments, helping them identify whether symptoms are isolated or part of a recurring pattern
DrTelX is licensed across all 50 states, and the named providers include Dr